We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Willing to Ease Postmarket Burdens to Get Support for QbD
FDA Willing to Ease Postmarket Burdens to Get Support for QbD
October 17, 2006
The FDA is taking steps to introduce more regulatory flexibility into postmarket reviews to get industry’s support for the agency’s Quality by Design (QbD) initiative, officials said.